Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Volk

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
Cancer|June 1, 1977
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)B Fisher, A Glass, C Redmond, et al.
Cancer|June 1, 1977
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trialB Fisher, E Montague, C Redmond, et al.
The New England Journal of Medicine|July 2, 1981
Treatment of primary breast cancer with chemotherapy and tamoxifenB Fisher, C Redmond, A Brown, et al.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
Cancer|June 1, 1977
L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)B Fisher, A Glass, C Redmond, et al.
Cancer|June 1, 1977
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trialB Fisher, E Montague, C Redmond, et al.
The New England Journal of Medicine|July 2, 1981
Treatment of primary breast cancer with chemotherapy and tamoxifenB Fisher, C Redmond, A Brown, et al.
The Journal of Small Animal Practice|November 18, 2021
Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritisS K Halstead, D S Gourlay, J Penderis, et al.
Pageof 5